BETHLEHEM, Pa., Dec. 2, 2013 /PRNewswire/ -- B. Braun Medical Inc. (B.Braun) will sponsor an exhibit theater presentation at the American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting in Orlando, FL, December 8th-10th.
The presentation, "Safe Compounding of Hazardous Drugs," will be presented by David Halterman, Director of Pharmacy, on Tuesday, December 10th from 11:30 a.m.-12:30 p.m. at the West Convention Center (end of aisle 800).
"B.Braun has made a longstanding commitment to eliminating preventable treatment errors and we are passionately committed to enhancing patient, clinician and environmental safety with products, services and education focused on sharing best clinical practices," said Rick Williamson, Vice President of Pharmaceutical Marketing at B.Braun.
B.Braun will showcase the following protective engineering device, compounding management system and CAPS® outsourcing admixture capabilities at booth (#1233) during ASHP:
About B. Braun
B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its "Sharing Expertise®" philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.
The B.Braun Group of Companies in the U.S. includes B.Braun, B.Braun Interventional Systems, Aesculap® and CAPS®. B.Braun's U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 46,000 employees in more than 50 countries throughout the world. To learn more about B.Braun visit www.BBraunUSA.com.
|SOURCE B. Braun Medical Inc.|
Copyright©2012 PR Newswire.
All rights reserved